NCT03316417View on ClinicalTrials.gov

Study of Adverse Renal Effects of Immune Checkpoints Inhibitors

CompletedOBSERVATIONAL
Enrollment

353

Participants

Timeline

Start Date

October 27, 2017

Primary Completion Date

October 27, 2017

Study Completion Date

October 27, 2017

Conditions
Adverse EffectRenal Toxicity
Interventions
OTHER

Renal Tolerance to Immunotherapy

The main objective is to describe the renal tolerance of these innovative therapies within a population homogeneous of patients.

Trial Locations (1)

69495

Department of Nephrology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03316417 - Study of Adverse Renal Effects of Immune Checkpoints Inhibitors | Biotech Hunter | Biotech Hunter